Avinash Bajaj
Overview
Explore the profile of Avinash Bajaj including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
97
Citations
916
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Agrawal R, Agarwal H, Mukherjee C, Chakraborty B, Sharma V, Tripathi V, et al.
Nucleic Acids Res
. 2025 Feb;
53(4).
PMID: 39997217
Upon exposure to ionizing irradiation, the MRE11-RAD50-NBS1 complex potentiates the recruitment of ATM (ataxia-telangiectasia mutated) kinase to the double-strand breaks. We show that the lack of BLM causes a decrease...
2.
Mehta D, Dua C, Chakraborty R, Yadav P, Dasgupta U, Bajaj A
Nanoscale Adv
. 2025 Feb;
PMID: 39967859
Docetaxel (DTX) is a highly effective chemotherapy drug commonly employed in the management of multiple cancers, such as breast, lung, and prostate cancer. However, its clinical usage is significantly hampered...
3.
Rana K, Yadav P, Chakraborty R, Jha S, Agrawal U, Bajaj A
ACS Appl Mater Interfaces
. 2025 Feb;
17(8):11595-11610.
PMID: 39946544
Chronic inflammation is mainly characterized by the release of proinflammatory cytokines (cytokine storm) and reactive oxygen/nitrogen species. Sepsis is a life-threatening condition resulting from the successive chronic inflammatory responses toward...
4.
Bhujel M, Kaloniya S, Jain D, Sripada L, Bajaj A, Rao G
Curr Med Chem
. 2025 Jan;
PMID: 39871569
Introduction: Arjunolic acid, a well-known natural product with various medicinal properties, was isolated from the heartwood of Terminalia arjuna. Various amides of arjunolic acid were synthesized using different aryl and...
5.
Mehta D, Rajput K, Jain D, Bajaj A, Dasgupta U
ACS Pharmacol Transl Sci
. 2024 Dec;
7(12):3758-3779.
PMID: 39698262
The mechanistic target of rapamycin kinase (MTOR) is pivotal for cell growth, metabolism, and survival. It functions through two distinct complexes, mechanistic TORC1 and mechanistic TORC2 (mTORC1 and mTORC2). These...
6.
Safwan S, Mehta D, Arora A, Khatol S, Singh M, Rana K, et al.
ACS Infect Dis
. 2024 Nov;
10(12):4146-4155.
PMID: 39564818
Polymicrobial wound infections caused by Gram-negative bacteria and associated inflammation are challenging to manage, as many antibiotics do not work against these infections. Utilizing adjuvants to repurpose the existing antibiotics...
7.
Dhingra S, Gaur V, Saini V, Rana K, Bhattacharyya J, Loho T, et al.
Biomater Sci
. 2024 Sep;
12(21):5644.
PMID: 39344713
Retraction of 'Cytocompatible, soft and thick brush-modified scaffolds with prolonged antibacterial effect to mitigate wound infections' by Shaifali Dhingra , , 2022, , 3856-3877, https://doi.org/10.1039/D2BM00245K.
8.
Rokkam S, Bhujel M, Jain D, Sripada L, Nanduri S, Bajaj A, et al.
RSC Adv
. 2024 Aug;
14(36):26625-26636.
PMID: 39175689
Globally, cancer is the most prevalent chronic disease-related cause of death. Although there are many anticancer drugs, some of them have adverse effects. Due to their limited side effects, natural...
9.
Yadav P, Rana K, Chakraborty R, Khan A, Mehta D, Jain D, et al.
Nanoscale
. 2024 May;
16(21):10350-10365.
PMID: 38739006
Tumour cells secrete various proangiogenic factors like VEGF, PDGF, and EGF that result in the formation of highly vascularized tumours with an immunosuppressive tumour microenvironment. As tumour growth and metastasis...
10.
Gaur P, Rajendran Y, Srivastava B, Markandey M, Fishbain-Yoskovitz V, Mohapatra G, et al.
Elife
. 2024 Apr;
12.
PMID: 38593125
Inflammation in ulcerative colitis is typically restricted to the mucosal layer of distal gut. Disrupted mucus barrier, coupled with microbial dysbiosis, has been reported to occur prior to the onset...